Max Bachrach

Partner, Patent Attorney

Max is a partner at VHPM. Before joining the firm in 2023, Max was Vice President of Intellectual Property at Lexicon Pharmaceuticals, where he formulated and implemented patent, trademark, and life-cycle management strategies for Lexicon’s platform technologies, antibodies, antibody conjugates, and small molecule drug candidates. Before Lexicon, Max litigated and prosecuted patents for a variety of clients in the biotechnology and pharmaceutical industries.

Max's favorite place to spend the summer: The Oregon coast

University of Virginia School of Law, J.D., 1998

California Institute of Technology, Ph.D., 1996

Columbia College, Columbia University, A.B., Chemistry, 1990

Wiedenfeld, D.; Bachrach, M.; McCleskey, T.M.; Hill, M.G.; Gray, H.B; and Winkler, J.R., “Temperature and Isotope Effects on the Rates of Photoinduced Iridium(I)‐Pyridinium Electron‐Transfer Reactions,” J. Phys. Chem. B, 101 (44), 8823‐8826, 1997.

Ponce, A.; Bachrach, M.; Farmer, P.J.; Winkler, J.R., “Intramolecular Electron Transfer in Cyanide-bridged Ruthenium Dimers,” Inorganica Chimica Acta, 243 (1-2), 135-140, 1996.

Han, R.; Bachrach, M.; Parkin, G., “Competitive Alkyl and Halide Metathesis in the Reactions of Grignard Reagents with Tl{η 3 -HB(3-Bu t pz) 3 },” Polyhedron, 9, 1775‐1778, 1990.